What is the CVR number of CRSG Denmark ApS?

CRSG Denmark ApS is registered with CVR / Virk under CVR 37084964.

What is the revenue of CRSG Denmark ApS?

CRSG Denmark ApS reported revenue of DKK 270K in 2024.

CRSG Denmark ApS employs 1 people as of the latest annual report.

Malin Birgitta Schmidt is the CEO of CRSG Denmark ApS, in role since 2023.

Daniel Fehr chairs the board of CRSG Denmark ApS, in role since 2021.

CRSG Denmark ApS's registered address is Herlev Bygade 14, 1..

APSActiveAdvertising protection

CVR 37084964Herlev Bygade 14, 2730 HerlevActivities of holding companies· NACE 6421Est. 2015 · 10 years old1 employees

Actively employed in the business

Name	Role	Member since
Current (1)
MB Malin Birgitta Schmidt Chief Executive Officer	Chief Executive Officer	2023
Former (7)
MR Mathias Riis Damgaard Management	Management	2023 – 2025
JF Johannes Franciscus Marie Kruijtzer Management	Management	2015 – 2016
SK Søren Kock Chief Executive Officer	Chief Executive Officer	2018 – 2021
FM Frans Maarten van Berckel Management	Management	2016 – 2018
JM Jens Mondrup Chief Executive Officer	Chief Executive Officer	2021 – 2023
JM Jerry Mathen George Management	Management	2018 – 2018
BK Bent Kemplar Management	Management	2015 – 2015

Non-executive oversight

Name	Role	Member since
Current (3)
RF Raoul Francis Dias Board of Directors	Board of Directors	2021
DF Daniel Fehr Chairman	Chairman	2021
CS Christopher Sebastian Östberg Board of Directors	Board of Directors	2025
Former (4)
JA Jacob Adelbertus Cornelis Vermeule Chairman	Chairman	2018 – 2018
Gv Gerard van Odijk Chairman	Chairman	2018 – 2019
CC Christiaan Cools Chairman	Chairman	2019 – 2021
BF Bart Frits A. Borms Board of Directors	Board of Directors	2018 – 2021

As of last annual report

Shareholder	Type	Ownership	Votes	Since
COLOSSEUMKLINIKKEN DANMARK ApS	Company	100%	100%	2023
Prophylaxis Participations B.V.	Individual	100%	100%	2017

Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.